Introduction
The GL-101 Glucose Analyser is manufactured in Japan by Mitsubishi Chemical Industries Ltd, and marketed in the UK by Anachem Ltd. A prototype machine was lent to the John Radcliffe Hospital, Oxford, during late 1982 and a modified model was installed in Good Hope Hospital, Sutton Coldfield, in early January 1983.
The analyser is designed solely for the estimation of glucose with sampling, calibration and production of result being completely automatic. It has the ability to analyse both plasma and urine samples and the sampling cycle can be interrupted at any time to accommodate emergency samples. The instrument is approximately 50cm high, 50cm wide and 50cm long and the only service required is a single electric output socket, although it is more convenient to site the analyser near a drain to take the waste solutions from the instrument. The sampler has a 40-position tray which accepts standard analyser cups and has an optional sample-identification system utilizing coded cards which fit over the cups. Sampling, dilution with water and the addition of phosphate buffer is achieved by means of automatic syringes. The diluted sample is pumped through a pretreatment column of basic anion-exchange resin, to remove possible interfering substances, before the addition of buffer and passage through a column of glucose oxidase (GOD) immobilized on glass beads. The manufacturer claims that 2000 samples can be passed through the pretreatment column and 500 samples through the GOD column before replacement is necessary. The amount of hydrogen peroxide formed is proportional to the glucose present and is measured by an electrode system positioned immediately above the enzyme column.
By identification of the cup containing the standard and the value of the standard, the analyser will calibrate itself and calculate and print-out the values of test samples. However, it is possible to override the manufacturer's standard value and enter any other positive integer.
The instrument samples at up to 120 samples/h utilizing 6/A of plasma (although requiring 20 #1 in the sample cup) or 2/B of urine. Results are printed on paper on a 24-column printer, in addition to being displayed by the LED screen; an RS 232C unidirectional interface card is available as an optional extra to allow direct transmission of results to a main laboratory computer.
Safety
The only moving parts accessible to the operator are the sampler probe and turntable. The small distance of travel of the sampler probe, facilitated by the compact design of the machine, is unlikely to present a hazard to the operator. The only reagents required are phosphate buffer and water and spillage of these onto the electronic components is unlikely.
Microbiological safety
The sampler area is easily cleaned but it is difficult to disinfect the tubing. Dissemination Cup Nos. 9, 11, 14, 15, 20, 21, 24, 27, 28, 34 37, 39.
Medium pool: Cup Nos. 6, 7, 12, 16, 18, 19, 22, 23, 26, 30, 31, 33. High pool: CupNos. 5, 8, 10, 13, 17, 25, 29, 32, 35, 36, 38, 40 value. It appears that Mitsubishi's quoted CV is based on one run of identical specimens; therefore the authors' figure, which includes the effect of carry-over and day-to-day variations, is a better indication of the precision one would expect to obtain in routine operation. Analysis of 40 consecutive aliquots of a 10mmol/1 standard gave a mean value of 10.02 mmol/1, SD of 0.09mmol/l and CV of 0.9, which meets the manufacturer's specification. Mitsubishi GL-101, [-] [-] Beckman glucose analyser. found to have an intercept Of 0.6 mmol/1 and a gradient of 0"98. Interference by the analgesics salicylate and paracetamol was assessed by adding these drugs to horse serum. Paracetamol, in particular, has been found to interfere with some glucose methods [5] . Sodium salicylate was found to have no effect, but 500mg/1 of paracetamol caused an increase in apparent serum glucose of approximately 0.8 mmol/1. A doseresponse curve using aqueous solutions of paracetamol showed a linear relationship up to at least g/1 (figure 9), however, the interference is not significant until high concentrations, only observed in very severe overdoses, are achieved.
Comparison with other methods
To test the effect of urine preservatives, boric acid (2 g/l), thiomersal (0.2 g/l), 6M hydrochloric acid (10ml/1) and benzoic acid (0"2 g/l) were added to separate aliquots ofa urine known to contain glucose. The 
Costs
To compare the costs of plasma glucose estimations on both machines only direct analytical costs were calculated since blood collection, separation of plasma, reporting of results and associated clerical work are common to both procedures. Costs were based on Good Hope annual work-load of approximately 15 000 samples; a number ofassumptions, described below, were necessary. Table 3 shows a breakdown of the expenses involved in running the Mitsubishi GL-101 and table 4 shows a similar analysis for the Beckman glucose analyser.
The capital cost per annum was based on a machine life of 10 years. The Beckman instrument was maintained on a fully inclusive service contract and the extra costs incurred for day-today maintenance were estimated at 150 per annum; however, the future maintenance costs of the Mitsubishi instrument were impossible to calculate and so were assumed to amount to 10 of the capital cost, as recommended by Broughton et al. [1] . 
Conclusions
The main impression was of a compact, well machined, simpleto-operate analyser, which generally performed well. The carryover figure was acceptable and the correlation with the existing methods was reasonable, although the bias at low concentrations of glucose with one instrument gave cause for concern. The effect of other carbohydrates, ascorbic acid, urinary preservatives, fluoride, oxalate and paracetamol were within acceptable limits but grossly haemolysed specimens should be avoided. Despite the high capital cost ofthe instrument, the cost per test compared favourably with that ofan alternative, widelyused instrument.
